BRIDGEWAY CAPITAL MANAGEMENT, LLC Q4 2020 Filing

Filed February 16, 2021

Portfolio Value

$4.7B

Holdings

1,303

Report Date

Q4 2020

Filing Type

13F-HR

All Holdings (1,303 positions)

#	Stock	Shares	Value	% Portfolio
1301	—CATABASIS PHARMACEUTICALS IN	12,500	$27K	0.00%
1302	LGL/WSLGL GROUP INC	34,200	$21K	0.00%
1303	NBYNOVABAY PHARMACEUTICALS INC	25,000	$17K	0.00%

PreviousPage 14 of 14